None of the squamous cell carcinomas (0%: 0 out of 32) or adeno/adenosquamous cell carcinomas (0%: 0 out of 48) had detectable oncogenic mutations in EGFR exons 18 through 21. This evidence concerns the gene EGFR and adenosquamous carcinoma.